Doron Dinstein
Plus aucun poste en cours
Profil
Doron Dinstein served as the Chief Executive Officer of Magnolia Medical Technologies Ltd.
He was previously the Manager-Cardiovascular Applications at Itamar Medical Ltd.
from 2004 to 2009.
From 2012 to 2019, he served as the Chief Medical Officer of Mazor Robotics Ltd.
He also worked as a Venture Partner at Entree Capital.
Dinstein holds an MBA from Northwestern University, an undergraduate degree from Tel-Aviv University, and a doctorate from Sackler School of Medicine.
Anciens postes connus de Doron Dinstein
| Sociétés | Poste | Fin |
|---|---|---|
| MAZOR ROBOTICS LTD | Directeur Technique/Scientifique/R&D | 01/08/2019 |
| ITAMAR MEDICAL LTD. | Corporate Officer/Principal | 01/01/2009 |
Entree Capital
 Entree Capital Investment ManagersFinance Entree Capital (Entree Capital) is a venture capital firm founded in 2004 by Avi Eyal and Martin Moshal. The firm is headquartered in London. | Private Equity Investor | - |
| Magnolia Medical Technologies Ltd. | President | - |
Formation de Doron Dinstein
| Tel-Aviv University | Undergraduate Degree |
| Sackler School of Medicine | Doctorate Degree |
| Northwestern University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Mazor Robotics Ltd.
 Mazor Robotics Ltd. Medical SpecialtiesHealth Technology Mazor Robotics Ltd. engages in the development and marketing of robotic guidance system for spinal surgery. Its product is Mazor X. The company was founded by Moshe Shoham and Eliyahu Zehavi in 2001 and is headquartered in Caesarea, Israel. | Health Technology |
| Magnolia Medical Technologies Ltd. | |
Itamar Medical Ltd.
 Itamar Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology Itamar Medical Ltd. engages in the research, development, marketing, selling, and leasing of non-invasive medical devices based on peripheral arterial tone signals. It develops and markets the WatchPAT and EndoPAT products. The WatchPAT diagnoses sleep apnea, a substantial risk factor in cardiac disease. The EndoPAT diagnoses endothelial malfunction, which is a predictor of cardiovascular disease. The company was founded by Yaron Giora , Martin Gerstel, Peretz Lavie, and Daniel Gur in 1995 and is headquartered in Caesarea, Israel. | Electronic Technology |
Entree Capital
Entree Capital Investment ManagersFinance Entree Capital (Entree Capital) is a venture capital firm founded in 2004 by Avi Eyal and Martin Moshal. The firm is headquartered in London. | Finance |
